From world-first breakthroughs in spinal cord repair, artificial heart technology and stroke intervention to Artificial ...

Bivacor's Total Artificial Heart gets FDA Breakthrough Device status, speeding development and possibly transforming heart-failure treatment.

HUNTINGTON BEACH, Calif., May 30, 2025--BiVACOR, a clinical-stage medical device company developing the world’s first titanium Total Artificial Heart (TAH), today announced that its device has ...

The patient, an Australian man in his 40s, lived with his fully functional heart implant long enough to be discharged from the hospital.

According to a statement from Monash University, the patient underwent a successful donor heart transplant on March 6, 2025, following 105 days with the BiVACOR Total Artificial Heart.

The recipient underwent a six-hour operation in November, surviving on the artificial heart for over 100 days until a donor heart transplant could occur in early March. BiVACOR CEO Dr Daniel Timms ...

Brisbane, Australia (CNN) — An Australian man lived for 100 days with an artificial titanium heart while he awaited a donor transplant, the longest period to date of someone with the technology.

An Australian man waiting for a heart transplant has survived 100 days with a BIVACOR titanium artificial heart while waiting for an organ to be prepared. A donor was found in March 2025 ...

An artificial heart implant has kept a local man alive for more than 100 days in a world-first surgical breakthrough at an Australian hospital.

An artificial heart implant has kept a local man alive for more than 100 days in a world-first surgical breakthrough at an Australian hospital.